コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nthetic genome that can be used to produce a synthetic cell.
2 and opening up its use in the generation of synthetic cells.
3 romolecular machines, metabolic networks and synthetic cells.
4 esting, biophysical studies and their use as synthetic cells.
5 crodroplets are finding increased utility in synthetic cell applications due to their cytomimetic pro
9 ese results suggest that the use of the P-15 synthetic cell-binding peptide combined with ABM yields
10 ese results suggest that the use of the P-15 synthetic cell-binding peptide combined with ABM yields
11 erived hydroxyapatite matrix combined with a synthetic cell-binding peptide P-15 (Putty P15) to deter
12 ith a bovine-derived xenograft coated with a synthetic cell-binding peptide; then the test group rece
14 mic control over protein distribution within synthetic cells comprising a lipid bilayer membrane surr
16 oluble Abeta oligomers from several sources (synthetic, cell culture, human brain extracts) facilitat
17 olling a wide range of in vitro chemistries, synthetic cell-free biochemical circuits promise to be u
18 port here on the development of a completely synthetic cell-free therapy based on peptide amphiphile
20 w available to generate rudimentary forms of synthetic cell-like entities, minimal progress has been
23 a simple method for the de novo creation of synthetic cell mimics in the form of giant polymeric ves
24 ent work and challenges in developing these "synthetic cell" models and their growing practical appli
25 assive simulations of particles diffusing in synthetic cells parameterized by morphometric statistics
27 in/TCF-dependent transcription, we developed synthetic cell-permeable analogs of beta-catenin's helix
31 urthermore, treating BMECs with cavtratin, a synthetic cell-permeable peptide encoding the caveolin-1
32 3-methyl-but-2-enyl diphosphate (HMBPP) or a synthetic cell-permeable prodrug, bis (pivaloyloxymethyl
33 everal families of readily prepared, totally synthetic, cell-permeable dimerizers composed of ligands
34 s available, control of gene expression with synthetic, cell-permeable molecules is within reach.
35 nto IGCs, and addition of a newly developed, synthetic, cell-permeable P/CAF inhibitor blocks this mo
38 ever, recent progress toward the creation of synthetic cells, ranging from simple protocells to artif
44 structures of the enzyme in complex with two synthetic cell-wall-based ligands, we present for the fi
45 e catalytic domain of LytA in complex with a synthetic cell-wall-based peptidoglycan (PG) ligand that
48 illustrate an approach for the evolution of synthetic cells with alternative biochemical building bl
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。